Dimensional Fund Advisors LP Raises Stock Position in Enhabit, Inc. (NYSE:EHAB)

Dimensional Fund Advisors LP lifted its stake in Enhabit, Inc. (NYSE:EHAB) by 1.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,756,745 shares of the company’s stock after purchasing an additional 26,753 shares during the period. Dimensional Fund Advisors LP owned 3.50% of Enhabit worth $15,669,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Gladius Capital Management LP purchased a new stake in Enhabit in the second quarter worth $31,000. Allspring Global Investments Holdings LLC bought a new stake in shares of Enhabit during the 1st quarter valued at $44,000. ProShare Advisors LLC purchased a new stake in shares of Enhabit in the 1st quarter worth about $118,000. Family Firm Inc. bought a new position in shares of Enhabit in the 1st quarter worth about $124,000. Finally, Covestor Ltd increased its stake in shares of Enhabit by 1,130.0% in the 1st quarter. Covestor Ltd now owns 13,456 shares of the company’s stock worth $157,000 after acquiring an additional 12,362 shares in the last quarter.

Enhabit Stock Down 1.2 %

NYSE:EHAB opened at $7.48 on Friday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.48 and a current ratio of 1.48. The firm has a market cap of $375.17 million, a P/E ratio of -4.51 and a beta of 1.81. Enhabit, Inc. has a fifty-two week low of $7.12 and a fifty-two week high of $11.74. The firm has a 50-day simple moving average of $8.36 and a two-hundred day simple moving average of $9.20.

Enhabit (NYSE:EHAB) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $0.07 earnings per share for the quarter, topping analysts’ consensus estimates of $0.05 by $0.02. The company had revenue of $260.60 million during the quarter, compared to analyst estimates of $265.99 million. Enhabit had a negative net margin of 0.84% and a positive return on equity of 1.61%. During the same period in the previous year, the business earned $0.04 EPS. Analysts predict that Enhabit, Inc. will post 0.26 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Jeffrey Bolton purchased 5,000 shares of Enhabit stock in a transaction dated Thursday, August 22nd. The stock was purchased at an average cost of $8.01 per share, for a total transaction of $40,050.00. Following the completion of the purchase, the director now directly owns 78,877 shares of the company’s stock, valued at $631,804.77. The trade was a 0.00 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Corporate insiders own 1.90% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Bank of America cut their price objective on shares of Enhabit from $9.00 to $8.00 and set an “underperform” rating on the stock in a report on Thursday, June 27th. One equities research analyst has rated the stock with a sell rating and six have given a hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $9.35.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.